Global Measles Market Growth (Status and Outlook) 2023-2029

Global Measles Market Growth (Status and Outlook) 2023-2029

Measles is a highly contagious infectious disease caused by the measles virus. Symptoms usually develop 10–12 days after exposure to an infected person and last 7–10 days. Initial symptoms typically include fever, often greater than 40 °C (104.0 °F), cough, runny nose, and inflamed eyes. Small white spots known as Koplik's spots may form inside the mouth two or three days after the start of symptoms. A red, flat rash which usually starts on the face and then spreads to the rest of the body typically begins three to five days after the start of symptoms. Complications occur in about 30% of cases and may include diarrhea, blindness, inflammation of the brain, and pneumonia, among others.

LPI (LP Information)' newest research report, the “Measles Industry Forecast” looks at past sales and reviews total world Measles sales in 2022, providing a comprehensive analysis by region and market sector of projected Measles sales for 2023 through 2029. With Measles sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Measles industry.

This Insight Report provides a comprehensive analysis of the global Measles landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Measles portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Measles market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Measles and breaks down the forecast by treatment, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Measles.

The global Measles market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

There is no specific antiviral treatment if measles develops. Instead the medications are generally aimed at treating super infections, maintaining good hydration with adequate fluids, and pain relief. Some groups are also given vitamin A, like young children and the severely malnourished, which act as an immunomodulator that boosts the antibody responses to measles and decreases the risk of serious complications.

This report presents a comprehensive overview, market shares, and growth opportunities of Measles market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by treatment
Antibiotic
Antiviral
Vaccine

Segmentation by application
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Abbott
Biomedical Diagnostics
Johnson & Johnson Services
Sanofi
Merck
Serum Institute Of India

Please note: The report will take approximately 2 business days to prepare and deliver.